查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056370

計算生物學市場報告：按應用、服務、最終用途和地區分類（2026-2034 年）

Computational Biology Market Report by Application, Services, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球計算生物學市場規模達81億美元。展望未來，IMARC Group預測，該市場在2026年至2034年間將以17.12%的複合年成長率成長，到2034年達到348億美元。推動該市場成長的主要因素是臨床研究的增加以及先進技術的融合。目前，北美佔據最大的市場佔有率，這主要得益於該地區眾多大型製藥和生物技術公司的聚集以及它們之間的廣泛合作。

計算生物學，又稱生物資訊學，是一門交叉學科，它運用數學、統計學和電腦科學來理解和模擬生命體的結構和過程。它涵蓋了生物學的各個方面，包括遺傳學、進化生物學、細胞生物學和生物化學。這個過程利用包括演算法在內的計算技術來表示和模擬生物系統，並大規模地解讀實驗數據。此外，計算生物學透過建構基於胺基酸序列、核苷酸和大分子結構等生物資訊的資料庫，為疾病治療方法和細胞功能的理解做出貢獻。如今，計算生物學已成為生物學研究計畫的重要組成部分，例如人類基因組計畫、蛋白質資料庫和基因組資料庫。

計算生物學市場的發展趨勢：

全球計算生物學市場的主要驅動力是藥物基因體學領域臨床研究數量的不斷成長。這使得人們對患者群體的多樣化生物組成、生物路徑和潛在基因組有了更深入的了解。因此，對計算生物學解決方案的需求日益成長，因為它們有助於縮短藥物發現和其他各種科學實驗所需的時間。這個過程也有利於用於模擬複雜藥物交互作用的工具的可視化。此外，表觀基因、蛋白質組學和總體基因體學對計算生物學的需求不斷成長，以闡明蛋白質結構和相互作用，這也推動了市場成長。此外，藥物發現和疾病建模方面的各種技術進步，以及私營和政府機構對研發活動的投入增加，預計在不久的將來為市場提供積極的推動力。

本報告解答的主要問題

  • 到 2025 年，全球計算生物學市場的規模將達到多少？
  • 2026年至2034年全球計算生物學市場的預期成長率為何？
  • 全球計算生物學市場的主要促進因素是什麼？
  • 新冠疫情對全球計算生物學市場產生了哪些影響？
  • 從應用領域來看，全球計算生物學市場是如何細分的？
  • 從服務角度來看，全球計算生物學市場是如何細分的？
  • 全球計算生物學市場依最終用途分類是怎樣的？
  • 全球計算生物學市場的主要區域有哪些？
  • 全球計算生物學市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球計算生物學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依應用領域分類

  • 細胞和生物模擬
    • 主要部分
      • 計算基因組學
      • 計算蛋白質體學
      • 藥物基因體學
      • 其他
  • 藥物發現與疾病建模
    • 主要部分
      • 目標識別
      • 目標驗證
      • 發現鉛
      • 先導藥物最適化
  • 臨床前藥物開發
    • 主要部分
      • 藥物動力學
      • 動態
  • 臨床試驗
    • 主要部分
      • 第一階段
      • 第二階段
      • 第三階段
  • 人體模擬軟體

第7章 市場區隔：依服務分類

  • 內部
  • 合約

第8章 市場區隔：依最終用途分類

  • 學術機構
  • 製藥業
  • 商業

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Certara
    • Chemical Computing Group ULC
    • Compugen Ltd
    • Dassault Systemes
    • Genedata AG
    • Insilico Biotechnology AG
    • Instem plc
    • Nimbus Therapeutics LLC
    • Schrodinger Inc.
    • Simulations Plus Inc.
Product Code: SR112026A4495

The global computational biology market size reached USD 8.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 34.8 Billion by 2034, exhibiting a growth rate (CAGR) of 17.12% during 2026-2034. The market is being driven by the rising number of clinical studies, along with integration of advanced technologies. At present, North America holds the largest market share, driven by the presence of leading pharmaceutical and biotechnology companies and various collaborations among companies.

Computational biology, also known as bioinformatics, is the interdisciplinary branch of science that uses math, statistics and computer science for understanding and modeling the structures and processes of life. It involves various aspects of biology, such as genetics, evolution, cell biology, and biochemistry. The process uses computational techniques, including algorithms, to represent and simulate biological systems and interpret experimental data on a large scale. Computational biology also helps understand the treatment for diseases and cellular function by creating a database of biological information from amino-acid sequences, nucleotides, and macromolecular structures. Nowadays, computational biology has become an essential part of biological research projects, including the human genome project, protein data banks and genomic databases.

Computational Biology Market Trends:

The global computational biology market is primarily driven by the rising number of clinical studies in the field of pharmacogenomics. This has helped increase the understanding of the diverse biological makeup of the patient population, biological pathways, and the genomes underpinning them. As a result, there is a high demand for computational biology solutions, as they help reduce the overall time needed for drug discovery and various other scientific experiments. The process also aids the visualization of tools to simulate advanced drug-drug interactions. In addition to this, the growing demand for computational biology in epi-genomics, proteomics, and meta-genomics to undertint protein structures and interactions is also propelling the market growth. Furthermore, various technological advancements in drug development and disease modeling, along with increasing investments by private and government organizations in research and development (R&D) activities, are also anticipated to provide a positive thrust to the market in the near future.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global computational biology market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on application, services and end use.

Breakup by Application:

  • Cellular and Biological Simulation
  • Computational Genomics
  • Computational Proteomics
  • Pharmacogenomics
  • Others
  • Drug Discovery and Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
  • Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
  • Clinical Trials
  • Phase I
  • Phase II
  • Phase III
  • Human Body Simulation Software

Cellular and biological simulation accounts for the majority of the market share

Researchers can better comprehend basic biological processes and the course of disease by using cellular and biological modeling. Cellular simulations are essential to drug discovery because they allow for virtual chemical screening, drug interaction prediction, and lead candidate optimization. As a result, this reduces the time and cost associated with traditional experimental approaches. The accuracy and dependability of cellular and biological simulations are improved by the development of complex simulation software and algorithms such as agent-based modeling and systems biology techniques. A thorough grasp of biological activities is made possible by the integration of simulations with proteomic, metabolomic, and genomic data.

Breakup by Services:

  • In-house
  • Contract

Contract holds the largest share of the industry

Contract services provide cost-effective solutions compared to maintaining in-house capabilities, particularly for smaller companies or those with limited resources. This trend is fostering more organizations to engage third-party providers for computational biology services. Contract service providers usually have access to the latest computational tools, technologies, and methodologies that allow clients to benefit from state-of-the-art solutions without the need for significant investment in infrastructure. Furthermore, contract services offer flexibility and scalability that allow companies to adjust the level of support based on project requirements.

Breakup by End Use:

  • Academics
  • Pharmaceutical Industry
  • Commercial

Commercial represents the leading market segment

The creation of novel treatments is becoming a top priority for commercial enterprises, necessitating the use of sophisticated computational tools for biological system modeling, medication interaction prediction, and data analysis. The commercial segment is growing as a result of pharmaceutical and biotechnology businesses' substantial spending in research and development (R&D) activities. Computational biology solutions are being used by businesses more and more in order to obtain a competitive edge in drug discovery. The integration of data science and machine learning (ML) into drug development processes is leading to a higher adoption of computational biology techniques in commercial settings.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest computational biology market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for computational biology.

North America is home to many leading pharmaceutical and biotechnology companies. The demand for computational biology solutions is significant in this region, as companies seek to streamline drug discovery and enhance their research and development (R&D) processes. The presence of well-established research institutions, universities, and laboratories equipped with advanced technologies fosters a conducive environment for computational biology. These institutions often collaborate with commercial entities, further driving the demand for computational services. Furthermore, top players in the region are developing new tools and methodologies that enhance research capabilities.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systemes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrodinger Inc. and Simulations Plus Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global computational biology market in 2025?
  • 2.What is the expected growth rate of the global computational biology market during 2026-2034?
  • 3.What are the key factors driving the global computational biology market?
  • 4.What has been the impact of COVID-19 on the global computational biology market?
  • 5.What is the breakup of the global computational biology market based on the application?
  • 6.What is the breakup of the global computational biology market based on the services?
  • 7.What is the breakup of the global computational biology market based on the end use?
  • 8.What are the key regions in the global computational biology market?
  • 9.Who are the key players/companies in the global computational biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Computational Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Cellular and Biological Simulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computational Genomics
      • 6.1.2.2 Computational Proteomics
      • 6.1.2.3 Pharmacogenomics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Drug Discovery and Disease Modelling
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Target Identification
      • 6.2.2.2 Target Validation
      • 6.2.2.3 Lead Discovery
      • 6.2.2.4 Lead Optimization
    • 6.2.3 Market Forecast
  • 6.3 Preclinical Drug Development
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Pharmacokinetics
      • 6.3.2.2 Pharmacodynamics
    • 6.3.3 Market Forecast
  • 6.4 Clinical Trials
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Phase I
      • 6.4.2.2 Phase II
      • 6.4.2.3 Phase III
    • 6.4.3 Market Forecast
  • 6.5 Human Body Simulation Software
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Services

  • 7.1 In-house
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Contract
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Academics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical Industry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Commercial
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Certara
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Chemical Computing Group ULC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Compugen Ltd
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Dassault Systemes
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genedata AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Insilico Biotechnology AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Instem plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Nimbus Therapeutics LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Schrodinger Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Simulations Plus Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Computational Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Computational Biology Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Computational Biology Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Computational Biology Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Computational Biology Market: Breakup by Services (in %), 2025
  • Figure 6: Global: Computational Biology Market: Breakup by End Use (in %), 2025
  • Figure 7: Global: Computational Biology Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Computational Biology (Cellular and Biological Simulation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Computational Biology (Cellular and Biological Simulation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Computational Biology (Drug Discovery and Disease Modelling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Computational Biology (Drug Discovery and Disease Modelling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Computational Biology (Preclinical Drug Development) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Computational Biology (Preclinical Drug Development) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Computational Biology (Clinical Trials) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Computational Biology (Clinical Trials) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Computational Biology (Human Body Simulation Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Computational Biology (Human Body Simulation Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Computational Biology (In-house) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Computational Biology (In-house) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Computational Biology (Contract) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Computational Biology (Contract) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Computational Biology (Academics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Computational Biology (Academics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Computational Biology (Pharmaceutical Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Computational Biology (Pharmaceutical Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Computational Biology (Commercial) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Computational Biology (Commercial) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Computational Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Computational Biology Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Computational Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Computational Biology Industry: SWOT Analysis
  • Figure 78: Global: Computational Biology Industry: Value Chain Analysis
  • Figure 79: Global: Computational Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Computational Biology Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Computational Biology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 3: Global: Computational Biology Market Forecast: Breakup by Services (in Million USD), 2026-2034
  • Table 4: Global: Computational Biology Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Computational Biology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Computational Biology Market: Competitive Structure
  • Table 7: Global: Computational Biology Market: Key Players